Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory

SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its Suzhou, China laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification. This achievement marks the company’s second CLIA certification in 2025, following its San Diego facility earlier this year, underscoring Crown Bioscience’s continued commitment to e
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks